BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37021255)

  • 1. Prognostic signature of endoplasmic reticulum stress-related long noncoding RNAs in head and neck squamous cell carcinoma: Association with somatic mutation and tumor immune microenvironment.
    Qu T; Miao C; Zhang Z; Li H; Liu L; Lin W; Li C; Pan J; Ye L; Cao Y
    J Dent Sci; 2023 Apr; 18(2):541-550. PubMed ID: 37021255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and validation of a prognostic signature based on seven endoplasmic reticulum stress-related lncRNAs for patients with head and neck squamous cell carcinoma.
    Zhou M; Li H; Hu J; Zhou T; Zhou L; Li Y
    Sci Rep; 2023 Dec; 13(1):22414. PubMed ID: 38104177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W; Ye Z; Chen L; Liang H; Cai Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of tumor immune microenvironment and cancer therapy for head and neck squamous cell carcinoma through identification of a genomic instability-related lncRNA prognostic signature.
    Jing L; Du Y; Fu D
    Front Genet; 2022; 13():979575. PubMed ID: 36105083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the Immune Microenvironment and Prognosis with a NETosis-Related lncRNA Signature in Head and Neck Squamous Cell Carcinoma.
    He X; Xiao Y; Liu S; Deng R; Li Z; Zhu X
    Biomed Res Int; 2022; 2022():3191474. PubMed ID: 36147630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel immune-related long non-coding RNA signature improves the prognosis prediction in the context of head and neck squamous cell carcinoma.
    Chen L; Cai Z; Lyu K; Cai Z; Lei W
    Bioengineered; 2021 Dec; 12(1):2311-2325. PubMed ID: 34167440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a novel endoplasmic reticulum stress-related lncRNA prognostic signature and candidate drugs in breast cancer.
    Cai J; Ji Z; Wu J; Chen L; Zheng D; Chen Y; Zhang X; Xie W; Huang J; Chen M; Lin R; Lin W; Chen Y; Li Z
    Front Genet; 2022; 13():949314. PubMed ID: 36092873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of an m6A-related lncRNA pair prognostic signature and prediction of the immune landscape in head and neck squamous cell carcinoma.
    Zhou C; Wang S; Shen Z; Shen Y; Li Q; Shen Y; Huang J; Deng H; Ye D; Zhan G; Li J
    J Clin Lab Anal; 2022 Jan; 36(1):e24113. PubMed ID: 34783061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cuproptosis-related LncRNAs are potential prognostic and immune response markers for patients with HNSCC via the integration of bioinformatics analysis and experimental validation.
    Zhou L; Cheng Q; Hu Y; Tan H; Li X; Wu S; Zhou T; Zhou J
    Front Oncol; 2022; 12():1030802. PubMed ID: 36620545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of endoplasmic reticulum stress-related lncRNAs in lung adenocarcinoma by bioinformatics and experimental validation.
    Xin T; Sun Y; Meng H; Zhang N; Peng B; Yang X; Hu J; Cao M
    Ann Med; 2023; 55(2):2251500. PubMed ID: 37643369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel Pyroptosis-related long non-coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma.
    Zhou C; Shen Y; Jin Y; Shen Z; Ye D; Shen Y; Deng H
    Cancer Med; 2022 Dec; 11(24):5097-5112. PubMed ID: 35567376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cuproptosis-Related lncRNAs are Biomarkers of Prognosis and Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
    Yang L; Yu J; Tao L; Huang H; Gao Y; Yao J; Liu Z
    Front Genet; 2022; 13():947551. PubMed ID: 35938003
    [No Abstract]   [Full Text] [Related]  

  • 13. Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinoma.
    Wei SY; Feng B; Bi M; Guo HY; Ning SW; Cui R
    BMC Med Genomics; 2022 Dec; 15(1):263. PubMed ID: 36528763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of immune-related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma.
    Li Q; Shen Z; Shen Y; Deng H; Shen Y; Wang J; Zhan G; Zhou C
    J Clin Lab Anal; 2022 Jun; 36(6):e24484. PubMed ID: 35561269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A N6-methyladenosine-related long noncoding RNAs model for predicting prognosis in oral squamous cell carcinoma: Association with immune cell infiltration and tumor metastasis.
    Yang Q; Cheng C; Zhu R; Guo F; Lai R; Liu X; Li M
    Oral Oncol; 2022 Apr; 127():105771. PubMed ID: 35189585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Validation of a Novel Genomic Instability-Associated Long Non-Coding RNA Prognostic Signature in Head and Neck Squamous Cell Carcinoma.
    Chen Y; Zhao Y; Lu R; Zhao H; Guo Y
    Front Cell Dev Biol; 2021; 9():787766. PubMed ID: 35127708
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification and in vitro validation of prognostic lncRNA signature in head and neck squamous cell carcinoma.
    Wang J; Bian Q; Liu J; Moming A
    Bioengineered; 2021 Dec; 12(2):10049-10062. PubMed ID: 34872450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune Infiltrates of m
    Feng ZY; Gao HY; Feng TD
    Front Cell Dev Biol; 2021; 9():672248. PubMed ID: 34178999
    [No Abstract]   [Full Text] [Related]  

  • 19. The Prognostic Value and Immune Landscapes of a m
    Wang E; Li Y; Ming R; Wei J; Du P; Zhou P; Zong S; Xiao H
    Front Cell Dev Biol; 2021; 9():718974. PubMed ID: 34917609
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of an endoplasmic reticulum stress-related signature with potential implications in prognosis and immunotherapy in head and neck squamous cell carcinoma.
    Fan X; Yang X; Guo N; Gao X; Zhao Y
    Diagn Pathol; 2023 Apr; 18(1):51. PubMed ID: 37087456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.